RTNB yields 2000000.00% · JNJ yields 2.14%● Live data
📍 RTNB pulled ahead of the other in Year 1
Combined, RTNB + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RTNB + JNJ for your $10,000?
root9B Holdings, Inc. provides cybersecurity and business advisory services primarily in regulatory risk mitigation in the United States and internationally. The company's Cyber Solutions segment offers cyber security, advanced technology training, operational support, and consulting services. This segment provides cyber operations assessments, analysis and testing, cyber training, forensics, exploitation, and strategic defense planning services. Its Business Advisory Solutions segment offers anti-money laundering (AML) operational, investigative, and remediation services, as well as AML risk advisory and consulting services in the areas of risk, data, organizational change, and cyber. This segment also conducts high-end investigations with expertise in services ranging from complex financial crime and intellectual property issues to conduct anti-bribery investigations or due diligence on a potential partner or customer. root9B Holdings, Inc. serves Fortune 500 companies, medium-sized businesses, and governmental entities. The company was formerly known as root9B Technologies, Inc. and changed its name to root9B Holdings, Inc. in December 2016. root9B Holdings, Inc. was founded in 1995 and is based in Phoenix, Arizona.
Full RTNB Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.